Selected Publications
ZMB Publications
Selected Publications
The list provides selected publications of the ZMB from 2004 to 2021, published in the journals listed below.
You can narrow the list down by year and author. If an error accured or no data was found, please reload or reset the page.
(View all ZMB publications via the interface of the university bibliography).
Journals
- ACS Nano
- Acta Neuropathologica
- Advanced Drug Delivery Reviews
- All Nature Journals
- American Journal of Human Genetics
- Angewandte Chemie International Edition
- Annals of Oncology
- Annual Review of Biochemistry
- Annual Review of Genetics
- Annual Review of Microbiology
- Biomaterials
- Biotechnology Advances
- Blood
- Brain
- Cancer Cell
- Cancer Discovery
- Cancer Research
- Cell
- Clinical Cancer Research
- Cell Reports
- Chemical Reviews
- Chemical Society Reviews
- Circulation
- Circulation Research
- Current Biology
- eLife
- EMBO Molecular Medicine
- EMBO Reports
- Endocrine Reviews
- European Heart Journal
- FEMS Microbiology Reviews
- Gastroenterology
- Genes and Development
- Gut
- Hepatology
- Immunity
- Immunological Reviews
- JAMA: Journal of the American Medical Association
- JAMA Oncology
- JAMA Neurology
- Journal of Hepatology
- Journal of the American Chemical Society
- Journal of the American Medical Association
- Journal of Clinical Oncology
- Journal of Hepatology
- Lancet
- Leukemia
- Molecular Cell
- Molecular Psychiatry
- Natural Product Research
- Nature
- Nature Biotechnology
- Nature Cancer
- Nature Cell Biology
- Nature Chemical Biology
- Nature Communications
- Nature Genetics
- Nature Medicine
- Nature Methods
- Nature Nanotechnology
- Nature Reviews Clinical Oncology
- Nature Reviews Molecular Cell Biology
- Nature Reviews Neurology
- Nature Structural & Molecular Biology
- Neuro-Oncology
- Nucleic Acids Research
- Proceedings of the National Academy of Sciences of the United States of America Science
- Science
- Science Advances
- Small
- The British Journal of Cancer
- The EMBO Journal
- The Journal of Cell Biology
- The Journal of Clinical Investigation (JCI)
- The Lancet
- The Lancet Diabetes and Endocrinology
- The Lancet Gastroenterology & Hepatology
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The New England Journal of Medicine
- Trends in Neurosciences
- Trends in Pharmacological Sciences
There were 1196 publications found
-
Condensins regulate resection-dependent DNA double-strand break repair pathways in replicated chromatinIn: Nucleic Acids Research, Vol. 54, 2026, Nr. 4, gkag076DOI (Open Access)
-
CUL4A-DDB1-DCAF10 is an N-recognin for N-terminally acetylated Src kinasesIn: Nature Communications, Vol. 17, 2026, Nr. 1, 132DOI (Open Access)
-
Molecular requirements for PLK1 activation by T-loop phosphorylationIn: The EMBO Journal, Vol. 45, 2026, Nr. 5, pp. 1496 – 1536DOI (Open Access)
-
Covalent modification of a glutamic acid inspired by HaloTag technologyIn: Nature Communications, Vol. 17, 2026, Nr. 1, 1257DOI (Open Access)
-
Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB–IV melanoma (KEYVIBE-010) : A randomised, double-blind, phase 3 studyIn: The Lancet Oncology, Vol. 27, 2026, Nr. 3, pp. 327 – 339DOI (Open Access)
-
PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)In: Annals of Oncology, Vol. 37, 2026, Nr. 5, pp. 686 – 700DOI (Open Access)
-
Adjuvant Imatinib or Observation in Patients with Gastrointestinal Stromal Tumors with KIT Exon 9 MutationsIn: JAMA Oncology, Vol. 12, 2026, Nr. 4, pp. 407 – 412
-
Sulfated glycosaminoglycans inhibit LCMV entry and modulate antiviral immunity and pathologyIn: EMBO Molecular Medicine, Vol. 18, 2026, Nr. 4, pp. 1235 – 1264DOI (Open Access)
-
Probing a Reactive Alkyne Center Aligned via a Triphenylmethane Tripod on Au(111) for Electric Field-Induced Chemistry by STM and TERSIn: Small, Vol. 22, 2026, Nr. 7, e09467DOI (Open Access)
-
Thyrotropin-releasing hormone neurons of different hypothalamic nuclei increase energy expenditureIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3499DOI (Open Access)
-
Discovery of an Endonuclease G-inhibitory Ku80-peptide protecting against leukemogenic rearrangements at the MLL breakpoint clusterIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3562DOI (Open Access)
-
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumorIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3397DOI (Open Access)
-
CCL3 is produced by aged neutrophils across cancers and promotes tumor growthIn: Cancer Cell, Vol. 44, 2026, Nr. 3, pp. 624 – 640.e12DOI (Open Access)
-
Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysisIn: Nature Communications, Vol. 17, 2026, Nr. 1, 3156DOI, Online Full Text (Open Access)
-
Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective nicheIn: Cancer Cell, Vol. 44, 2026, Nr. 1, pp. 94 – 111.e11DOI (Open Access)
-
Combined targeted and epigenetic-based therapy enhances antitumor immunity by stabilizing GATA6-dependent MHCI expression in pancreatic ductal adenocarcinomaIn: Nature Communications, Vol. 17, 2026, Nr. 1, 1476DOI (Open Access)
-
Molecular anatomy of PLK1 master docking motifsIn: Nature Communications, Vol. 17, 2026, Nr. 1, 4228DOI (Open Access)
-
Heart failure therapy in patients with advanced cancer receiving specialized palliative care (EMPATICC trial)In: European Heart Journal, Vol. 47, 2026, Nr. 9, pp. 1034 – 1046DOI (Open Access)
-
PDS5 proteins control genome architecture by limiting the lifetime of cohesin-NIPBL complexesIn: Molecular Cell, 2026, in pressDOI (Open Access)
-
Unifying Scaling Relations and Multiple Reaction Mechanisms for Screening Transition Metal-Doped Co3O4 for Oxygen Evolution ReactionIn: Angewandte Chemie International Edition, 2026, e24523 , in pressDOI (Open Access)
-
Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastomaIn: The Journal of Clinical Investigation (JCI), Vol. 136, 2026, Nr. 7, 189152DOI (Open Access)
-
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanomaIn: Annals of Oncology, Vol. 37, 2026, Nr. 7, pp. 999 – 1010DOI (Open Access)
-
Direct observation of ATP-driven ubiquitin chain handling by Cdc48In: Nature Communications, Vol. 17, 2026, Nr. 1, 6014DOI (Open Access)
-
Years of life lost in patients with a false-negative diagnosis of primary melanoma : A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 yearsIn: Nature Communications, Vol. 17, 2026, Nr. 1, 5790DOI (Open Access)
-
Pulsed-Laser Ablation for the Synthesis of High-Entropy Alloy Aerogels Toward H2O2 Production and Water DecolorizationIn: Angewandte Chemie International Edition, 2026, e2026722 , in pressDOI (Open Access)
-
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesisIn: Blood, 2026, in pressDOI (Open Access)
-
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects: International Cardio-Oncology Society Position StatementIn: JAMA Oncology, Vol. 12, 2026, Nr. 1, pp. 90 – 99
-
Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal LeukoencephalopathyIn: JAMA Neurology, Vol. 83, 2026, Nr. 3, pp. 280 – 289DOI (Open Access)
-
Targeted Radiation, Unintended EvolutionIn: Clinical Cancer Research, Vol. 32, 2026, Nr. 13, pp. 2527 – 2529
-
Lymph node environment drives FSP1 targetability in metastasizing melanomaIn: Nature, Vol. 649, 2026, Nr. 8096, pp. 477 – 486DOI (Open Access)
-
Diversity and distinctive characteristics of the global RNA virome in urban and peri-urban environmentsIn: Nature Communications, Vol. 17, 2026, Nr. 1, 6397DOI (Open Access)
-
Ancient co-option of LTR retrotransposons as yeast centromeresIn: Nature, Vol. 651, 2026, Nr. 8107, pp. 1004 – 1011DOI (Open Access)
-
l-2-Hydroxyglutarate impairs neuronal differentiation through epigenetic activation of MYC expressionIn: The Journal of Clinical Investigation (JCI), Vol. 136, 2026, Nr. 9, e197010DOI (Open Access)
-
Genome-wide histone humanization in yeast disrupts genome organization, replication, and rDNA stabilityIn: Cell Reports, Vol. 45, 2026, Nr. 6, 117484DOI (Open Access)
-
New prostate cancer risk groups by PSMA-PET (PPP3) : An international, retrospective, registry-based cohort studyIn: The Lancet Oncology, Vol. 27, 2026, Nr. 4, pp. 480 – 490DOI (Open Access)
-
Type I IFN-dependent FcγRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infectionsIn: The Journal of Clinical Investigation (JCI), Vol. 136, 2026, Nr. 4, e192371DOI, Online Full Text (Open Access)
-
Atomic-Scale Understanding of Selectivity Control in Nitrate Reduction on Cu(100) Under Acidic and Alkaline ConditionsIn: Angewandte Chemie International Edition, 2026, in pressDOI (Open Access)
-
The accessory adapters FAF1, FAF2, and UBXN7 accelerate proteasomal degradation by increasing prior p97-mediated substrate unfoldingIn: Science Advances, Vol. 12, 2026, Nr. 10, eaea7381DOI, Online Full Text (Open Access)
-
Reverse engineering of BNIP3 identifies a mitochondrial protective peptideIn: Nature Communications, Vol. 17, 2026, Nr. 1, 5359DOI (Open Access)
-
Activated ATF6α is a hepatic tumour driver restricting immunosurveillanceIn: Nature, Vol. 651, 2026, Nr. 8106, pp. 796 – 807DOI (Open Access)
-
Deep Learning-Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metastatic Colorectal CancerIn: Clinical Cancer Research, Vol. 32, 2026, Nr. 5, pp. 938 – 946
-
Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K–Mutant Advanced or Metastatic MelanomaIn: Clinical Cancer Research, Vol. 32, 2026, Nr. 7, pp. 1266 – 1276DOI (Open Access)
-
Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitorsIn: Nature Communications, Vol. 17, 2026, Nr. 1, 4331DOI (Open Access)
-
M18BP1 valency and a distributed interaction footprint determine epigenetic centromere specification in humansIn: The EMBO Journal, Vol. 45, 2026, Nr. 5, pp. 1537 – 1572DOI (Open Access)
-
SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic VulnerabilitiesIn: Cancer Discovery, Vol. 16, 2026, Nr. 8, pp. 1666 – 1690DOI, Online Full Text (Open Access)
-
Genetic and functional analyses of CTBP2 in anorexia nervosa and body weight regulationIn: Molecular Psychiatry, Vol. 30, 2025, Nr. 5, pp. 1836 – 1846DOI (Open Access)
-
HBV shows different levels of adaptation to HLA class I-associated selection pressure correlating with markers of replicationIn: Journal of Hepatology, Vol. 82, 2025, Nr. 5, pp. 805 – 815DOI (Open Access)
-
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialIn: Nature Medicine, Vol. 31, 2025, Nr. 1, pp. 152 – 164DOI (Open Access)
-
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancerIn: Nature Communications, Vol. 16, 2025, Nr. 1, 335DOI (Open Access)